AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimizide M SR 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Panvik Pharmaceuticals

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimizide M SR 1mg/500mg Tablet

Glimizide M SR 1mg/500mg tablets are classified as antidiabetic medications, a dual-drug formulation for adult type 2 diabetes management. This medication helps regulate blood sugar. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can elevate blood glucose, potentially leading to complications including nephropathy, retinopathy, neuropathy, and limb loss. This medicine is just one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and have readily available glucose (e.g., sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimizide M SR 1mg/500mg Tablet

The provided text is "undefined," so there is nothing to rephrase.

Uses of Glimizide M SR 1mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glimizide M SR 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimizide M SR 1mg/500mg Tablet should be administered with a meal.

Common Side effects of Glimizide M SR 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimizide M SR 1mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Glimizide M SR 1mg/500mg tablet should be administered with a meal.

How Glimizide M SR 1mg/500mg Tablet works:

Glimepiride/Metformin 1mg/500mg tablets (e.g., Glimizide M SR) combine two antidiabetic agents to manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose uptake, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimizide M SR 1mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimizide M SR 1mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release glimipiride/metformin 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Glimizide M SR 1mg/500mg tablets require careful consideration for patients with impaired kidney function. Dosage modification of Glimizide M SR 1mg/500mg tablets may be necessary. Physician consultation is recommended. In cases of severe kidney disease, Glimizide M SR 1mg/500mg tablets are contraindicated. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimizide M SR 1mg/500mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. In individuals with mild to moderate liver disease, treatment typically begins with a low Glimizide M SR 1mg/500mg tablet dosage; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimizide M SR 1mg/500mg Tablet :

Should you forget to take a Glimizide M SR 1mg/500mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimizide M SR 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Medication

FAQs on Glimizide M SR 1mg/500mg Tablet

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimizide M SR 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid. Also known as MALA (Metformin-associated lactic acidosis), this rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Glimizide M SR 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glimizide M SR 1mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimizide M SR 1mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary dysfunction, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimizide M SR 1mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimizide M SR 1mg/500mg tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimizide M SR 1mg/500mg ...
25
MRP 30
16% off